Not Tagged
Not Tagged
['sclc']
 very disappointing to see another sclc trial as negative. remains a really challenging disease. thoughts as to the slight improvement in os compared to previous studies particularly as appropriately allowed patients with asymptomatic bm (with slightly worse prognosis)?
consultant medical oncologist with interests in lung cancer, new cancer therapies and biomarkers. (all views are my own and do not represent my employers)